Business
Commence of roll out in Greater Manchester
Commence of roll out in Greater Manchester.
About this update from Genedrive Plc
[{"type":"text","content":"\n \n \n \n genedrive plc\n \n \n \n \n (\"genedrive\" or the \"Company\")\n \n \n \n \n \n \n \n Genedrive\n \n ®\n \n MT-RNR1 to commence roll out in Greater Manchester\n \n \n \n \n Project to follow NICE final recomendations scheduled for end of this month\n \n \n \n \n \n \n genedrive plc (AIM:GDR), the point of care molecular diagnostics company, announces that the Genedrive® MT-RNR1 ID Kit is in process for roll out at two further hospital sites in the North West NHS. The implementation project, scheduled to commence from April, will follow the NICE final recommendation for the use of the Genedrive MT-RNR1 ID test in the NHS (England and Wales) which is due towards the end of this month.\n \n \n \n \n \n The Manchester Academic Health Science Centre (MAHSC) Women and Children Domain, part of Health Innovation Manchester (HInM) are supporting and project managing the further roll out across Manchester University NHS Foundation Trust. The Company continues to work alongside HInM on specific plans for the roll out across an additional five neonatal sites in Greater Manchester. Once fully subscribed at this regional level, the test would be available when needed to circa 30000 newborns over the next NHS fiscal year, of which 10-12% are modelled to be admitted to a regional neonatal unit.\n \n \n \n \n \n MAHSC is one of eight national centres designated by NHS England and the National Institute for Health and Care Research for demonstrating excellence in patient care and driving innovation into the health service.\n \n \n \n \n \n \n Dr. Ajit Mahaveer, Clinical Head of Division - Newborn Services, Manchester University NHS Foundation Trust (MFT)\n \n said: \"The Genedrive MT-RNR1 test was piloted here at MFT. This initiative will allow us to expand testing to the neonatal units at North Manchester General Hospital and Wythenshawe Hospital. We are also intending to work with NICE on ongoing data collection to support the long term recommendations for the product.\"\n \n \n \n \n \n \n Jonathan Massey, Programme Director for Academia at Health Innovation\n \n \n Manchester said: \"The Genedrive MT-RNR1 test was developed alongside our NHS partners and supported by the National Institute for Health and Care Research. This programme will support its wider adoption across...